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Objective: Many preoperative, intraoperative, and postoperative methods have been described that
improve the outcomes of women with severe Asherman syndrome, and it is likely that an integrated
application of all of these methods may provide better reproductive outcomes; however, there is as yet
no report on this type of integrated approach.
Materials and methods: The cases of four infertile women with severe Asherman syndrome were
analyzed retrospectively. The comprehensive therapeutic plan for the four women included (1) preop-
erative ofﬁce hysteroscopy to conﬁrm the diagnosis and evaluate the severity of disease; (2) the use of
ultrasound-guided intraoperative abdominal procedures during the surgical procedure, including hys-
teroscopic adhesiolysis to ensure the entire the hysteroscopic dissection, and placement of a Hyalo-
barrier® gel and an intrauterine balloon catheter at the end of the surgery; (3) postoperative oral
estrogen supplementation to enhance endometrial proliferation, removal of the balloon catheter, and a
second-look ofﬁce hysteroscopy; and (4) in vitro fertilization and embryo transfer (IVF & ET) for three of
the four patients.
Result: After treatment, the endometriumwas signiﬁcantly thicker than at baseline (median endometrial
thickness, 7.5 mm versus 3.0 mm, p < 0.05). All the women (100%, 4/4) conceived successfully (three
undergoing IVF & ET, and one had a spontaneous pregnancy), but only two patients had a term preg-
nancy with cesarean section (one placenta previa and the other placental abruption), contributing to 50%
of successful term pregnancies. One patient had the complication of abortion after amniocentesis. The
last one woman underwent an abortion because of thyroid problems.
Conclusion: Comprehensive management offers promising reproductive outcomes for infertile women
with severe Asherman syndrome.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.epartment of Obstetrics and
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Asherman syndrome is a consequence of trauma to the endome-
trium,producingpartial or complete obliteration in theuterine cavity
and/or the cervical canal, resulting in conditions such as menstrual
abnormalities, infertility, and recurrent pregnancy loss [1]. Although
trauma to a gravid uterine cavity is known to be the main cause ofby Elsevier Taiwan LLC. All rights reserved.
Table 1
Patients with severe-type Asherman syndrome and outcomes.
Patient Age (y) D & C history TCR history Infertility Other infertility factors EM thickness (Pre Tx/Post Tx) Pregnancy outcome
1 36 D & C  2 No SI for 2 y Endometriosis, tubal occlusion 3.0/8.0 mm 18 wk, PPROM, abortion
2 36 D & C  3 Yes (once) SI for 1 y; AIH  1 Adenomyosis 2.0/7.0 mm 38 wk, placenta previa, CS
3 35 D & C  2 No SI for 1 y Tubal occlusion
Ovulation dysfunction
4.0/9.0 mm 38 wk, placenta abruption, CS
4 38 D & C  3 No SI for 1 y 3.0/6.0 mm 8 wk, spontaneous abortiona
AIH ¼ artiﬁcial insemination by husband; CS ¼ cesarean section; D & C ¼ dilatation and curettage; EM ¼ endometrium; PPROM ¼ preterm premature rupture of membranes;
SI ¼ secondary infertility; TCR ¼ transcervical resection; Tx ¼ treatment; wk ¼ gestational age in weeks.
a The reason was secondary to thyroid disease.
Table 2
Comprehensive management of severe Asherman syndrome.
Preoperative
Transvaginal ultrasound (TVS) to assess baseline endometrial thickness and
evaluate pelvic anatomy
Ofﬁce hysteroscopy to conﬁrm diagnosis and identify extent of adhesions
Intraoperative
Transabdominal ultrasound (TAS)-guided cervical and uterine dilatation
TAS-guided adhesiolysis of uterine synechiae
TAS-guided insertion of Hyalobarrier gel into uterine cavity
TAS-guided placement of intrauterine balloon catheter
Postoperative
Remove intrauterine balloon catheter 1 wk after surgery
Ofﬁce hysteroscopy within 2 wk after surgery
Estrogen supplementation for 8~10 wk after ofﬁce hysteroscopy
TVS to assess posttreatment endometrial thickness
Active assisted-reproductive technique, including in vitro fertilization and
embryo transfer if endometrial thickness  6 mm
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syndrome [1]. Many preoperative, intraoperative, and postoperative
methods have been described that improve the surgical outcomes of
women with severe Asherman syndrome. These methods include
direct inspection with hysteroscopy to accurately conﬁrm the diag-
nosis anddisease severity [2], transvaginal ultrasound (TVS) to assess
the preoperative prognosis [3], laparoscopy-guided or trans-
abdominal ultrasound (TAS)-directed hysteroscopic lysis of the syn-
echiae [4], placement of physical barriers into the uterine cavity [5,6],
second-look ofﬁce hysteroscopy [7,8], estrogen supplementation to
enhance endometrial proliferation, [9] and agents to increase
vascular ﬂow to the endometrium [10].
The integrated application of all of these methods may lead to
better reproductive outcomes, but no reports on this approach are
available so far. In the current study, we report our experience and
the reproductive outcomes using these combined proceduresda
comprehensive preoperative, intraoperative, and postoperative
approach for infertile women with severe Asherman syndrome.
Materials and methods
A complete retrospective chart review was performed to iden-
tify infertile women who underwent comprehensive treatment of
severe Asherman syndrome by one surgeon (Dr Tsui) at the
Reproductive Center in Kaohsiung Veterans General Hospital from
2011 through 2012. The diagnosis of severe-type Asherman syn-
drome (scores 9e12) was conﬁrmed by preoperative hysteroscopy,
in accordance with the American Fertility Society (AFS) Classiﬁca-
tion of Uterine Adhesions [11]. Baseline endometrial thickness,
pelvic anatomy, and cause of infertility were evaluated by TVS and
laboratory examination [12].
All intraoperative procedureswere guided by TASwith adequate
distension of the urinary bladder, including hysteroscopic adhe-
siolysis, adhesion prevention, and intrauterine balloon positioning.
TAS-guided hysteroscopic adhesiolysis included a well-distended
urinary bladder, adequate and delicate dilation of the cervical ca-
nal and endometrial cavity, and hysteroscopic lysis of an intra-
uterine adhesion by hysteroscopy scissors and a bipolar electrode
using a controlled ﬂow pump with normal saline for distention. A
one-step procedure to restore the normal dimension of the uterine
cavity was performed for all patients.
At the end of the hysteroscopic adhesiolysis, a Hyalobarrier gel
and a triangular intrauterine balloon catheter (Cook Medical) [13]
were placed and inﬂated at the uterine fundus under abdominal
ultrasound guidance. The balloon catheter was removed one week
after surgery.
A second-look ofﬁce hysteroscopy was performed within
2 weeks after surgery, and estrogen supplementation (estradiol
acetate 2 mg, twice per day) was provided for 8 to 10 weeks after
the ofﬁce hysteroscopy. Postoperative TVS was used to evaluate
endometrial thickness after estrogen supplementation. In vitro
fertilization and embryo transfer (IVF & ET) were performed when
endometrial thickness had reached 6 mm at least. If posttreatmentendometrial thickness did not reach 6 mm at least, combined es-
trogen and agents to increase vascular ﬂow to the endometrium
(e.g., vitamin E, L-arginine, sildenaﬁl citrate) were administered
until the desired endometrial thickness was attained [10]. Response
to treatment was determined by subsequent achievement of
pregnancy and live birth (Table 1).
Results
The ages of the patients ranged from 35e38 years. All women
had undergone dilation and curettage at least twice after preg-
nancy and Patient 2 underwent previous hysteroscopic surgery. All
the women had amenorrhea and secondary infertility caused by
Asherman syndrome. A comprehensive therapeutic plan, including
preoperative evaluation, and intraoperative as well as post-
operative management, was applied with all four patients (Table 2).
During the surgical procedure, no uterine perforation occurred.
After treatment, the endometriumwas signiﬁcantly thicker than at
baseline (median endometrial thickness, 7.5 mm versus 3.0 mm,
p < 0.05). All the women conceived successfully (three undergoing
IVF & ET, and one had a spontaneous pregnancy), but only two
patients had a term pregnancy with cesarean section (one placenta
previa and the other placental abruption). Three of the four patients
underwent amniocentesis because of the indication of advanced
maternal age [14,15]; however, one patient had the complication of
abortion after amniocentesis. The last patient underwent abortion
because of thyroid problems.
Discussion
A comprehensive approach to infertile women with Asherman
syndrome, including accurate diagnosis, elaborate surgery,
methods to reduce adhesion reformation, active assisted repro-
ductive technology, and ongoing surveillance of pregnancies up to
delivery, has been demonstrated to optimize outcomes.
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diagnosis but also for therapy [16]. Hysteroscopy allows direct in-
spection of the uterine cavity for diagnosis, classiﬁcation, and
treatment, and more accurately conﬁrms the presence, extent, and
degree of adhesions and the quality of the endometrium [2]. In the
diagnosis of intrauterine adhesions, hysterosalpingography and
sonohysterography have similar sensitivity but high false-positive
rates (sensitivity 75%; speciﬁcity 93~95%; and positive predictive
value 43e50%) [17], but HSG may provide additional information
about the patency of the fallopian tubes. Although the diagnostic
ability of TVS alone for intrauterine adhesion is limited [17], pre-
operative endometrial thickness was reported to correlate with the
outcome of treatment [3]. Therefore, TVS is still useful.
Hysteroscopic adhesiolysis using scissors may minimize the
destruction of the endometrium, and electrosurgery with a bipolar
electrodemay induce less collateral damage thanwith a monopolar
electrode. Guidance for difﬁcult hysteroscopic surgeries is neces-
sary to avoid uterine perforation. Although laparoscopy is available
for guidance, it is usually too late to prevent uterine perforation.
TAS guidance might be a better choice, because it costs less and has
a lower uterine perforation rate [4].
Preventing recurrent intrauterine adhesions is essential to suc-
cessful treatment, because reformation of intrauterine adhesions is
common, especially in severe-type Asherman syndrome. Hyal-
uronic acid, a natural component of the extracellular matrix, the
vitreous humor, and synovial ﬂuid of the joint, has been proposed
as a barrier agent to prevent adhesion formation [1]. A systematic
review and meta-analysis reported that application of auto-
crosslinked hyaluronan gel signiﬁcantly reduced the number of
women with intraperitoneal adhesions after laparoscopic myo-
mectomy [odds ratio (OR) 0.248, 95% conﬁdence interval (CI)
0.098e0.628] and the number of women with intrauterine adhe-
sions after hysteroscopic surgery (OR 0.408, 95% CI 0.217, 0.766) [5].
The insertion of an intrauterine device (IUD) was a widely used
method to prevent adhesion reformation in the past [7], but
copper-containing IUDs and T-shaped IUDs are not recommended
because of their inﬂammation-provoking properties and small
surface area, respectively [18]. The use of a Foley catheter inserted
into the uterine cavity for several days after hysteroscopic surgery is
reported to prevent recurrence of intrauterine adhesions [6]. A
Cook intrauterine balloon with a triangular shape can conform
completely to the conﬁguration of a uterine cavity and sustain
separation at the margins of the uterine cavity, which is the most
common site of reformation [19]. A recent comparison study
showed that the insertion of an intrauterine balloon or intrauterine
device is more effective than the use of hyaluronic acid gel in the
prevention of intrauterine adhesion reformation [20]. We suggest
the two strategies could be used simultaneously, to better effect,
although no study has tested this hypothesis.
Ofﬁce hysteroscopy is useful for both diagnosis and second-look
follow-up after treatment of intrauterine adhesions. Several studies
showed that an early second-look ofﬁce hysteroscopy, performed
within 2 weeks after primary treatment of intrauterine adhesions,
can bluntly lyse newly forming ﬁlmy adhesions before they become
dense and vascularized and signiﬁcantly reduce the reformation of
intrauterine adhesions [7,8].
Estrogen is often used to promote endometrial proliferation
and healing after surgery. Farhi et al [9] demonstrated a signiﬁ-
cant increase in endometrial thickness and volume following
estrogen therapy after curettage for ﬁrst-trimester abortion
compared with patients who were not treated. Preoperative es-
trogen therapy has also been suggested to be of potential beneﬁt
in increasing endometrial thickness before surgical intervention
[21]. Takasaki et al [10] reported the use of sildenaﬁl citrate
(100 mg/day, intravaginally). L-Arginine (6 g/day) or vitamin E(600 mg/day) has shown increased endometrial thickness and an
improvement in radial artery-resistance indices. We did not use
this extra treatment; therefore, further research may be required
to evaluate the efﬁcacy and possible adverse effects because of the
off-label use.
In conclusion, after active and comprehensive treatment,
restored menstruation and thickness of the endometrium could be
achieved, which contributed to the possibility of patients with
severe-type Asherman syndrome becoming pregnant.Conﬂicts of interest
The authors have no conﬂicts of interest relevant to this article.Acknowledgments
This work was supported in part by grants from Kaohsiung
Veterans General Hospital (KSB1101-032, KSB2101-005, KSB2102-
004, and KSB2103-005 to K.-H.), and the Ministry of Science and
Technology, Executive Yuan (NSC 102-2314-B-010-032 and MOST
103-2314-B-010 -043 -MY3 to P.-H.), and Taipei Veterans General
Hospital (V101C1-128; V102C-141; V101E5-006; V102E4-003;
V103A-016; V103C-112; V103E4-003 to P.-H.).References
[1] Yu D, Wong YM, Cheong Y, Xia E, Li TC. Asherman syndromeeone century
later. Fertil Steril 2008;89:759e79.
[2] Wamsteker K. Intrauterine adhesions (synechiae). In: Brosens I, Wamsteker K,
editors. Diagnostic imaging and endoscopy in gynecology: a practical guide.
London: WB Saunders; 1997. p. 171e84.
[3] Schlaff WD, Hurst BS. Preoperative sonographic measurement of endometrial
pattern predicts outcome of surgical repair in patients with severe Asher-
man's syndrome. Fertil Steril 1995;63:410e3.
[4] Kresowik JD, Syrop CH, Van Voorhis BJ, Ryan GL. Ultrasound is the optimal
choice for guidance in difﬁcult hysteroscopy. Ultrasound Obstet Gynecol
2012;39:715e8.
[5] Mais V, Cirronis MG, Peiretti M, Ferrucci G, Cossu E, Melis GB. Efﬁcacy of auto-
crosslinked hyaluronan gel for adhesion prevention in laparoscopy and hys-
teroscopy: a systematic review and meta-analysis of randomized controlled
trials. Eur J Obstet Gynecol Reprod Biol 2012;160:1e5.
[6] Vrachnis N, Salakos N, Iavazzo C, Grigoriadis C, Iliodromiti Z, Siristatidis C,
et al. Bakri balloon tamponade for the management of postpartum hemor-
rhage. Int J Gynaecol Obstet 2013;122:265e6.
[7] Pabuccu R, Onalan G, Kaya C, Selam B, Ceyhan T, Ornek T, et al. Efﬁciency and
pregnancy outcome of serial intrauterine device-guided hysteroscopic adhe-
siolysis of intrauterine synechiae. Fertil Steril 2008;90:1973e7.
[8] Robinson JK, Colimon LM, Isaacson KB. Postoperative adhesiolysis therapy for
intrauterine adhesions (Asherman's syndrome). Fertil Steril 2008;90:409e14.
[9] Farhi J, Bar-Hava I, Homburg R, Dicker D, Ben-Rafael Z. Induced regeneration
of endometrium following curettage for abortion: a comparative study. Hum
Reprod 1993;8:1143e4.
[10] Takasaki A, Tamura H, Miwa I, Taketani T, Shimamura K, Sugino N. Endo-
metrial growth and uterine blood ﬂow: a pilot study for improving endo-
metrial thickness in the patients with a thin endometrium. Fertil Steril
2010;93:1851e8.
[11] The American Fertility Society classiﬁcations of adnexal adhesions, distal tubal
occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies,
mullerian anomalies and intrauterine adhesions. Fertil Steril 1988;49:944e55.
[12] Chang WH, Wang KC, Lee NR, Huang N, Su WH, Chao HT, et al. Reproductive
performance of severely symptomatic women who wanted preservation of
the uterus and underwent combined surgical-medical treatment for uterine
adenomyoma. Taiwan J Obstet Gynecol 2013;52:39e45.
[13] Tsui KH, Lin LT, Yu KJ, Chen SF, Chang WH, Yu S, et al. Double-balloon cervical
ripening catheter works well as an intrauterine balloon tamponade is post-
abortion massive hemorrhage. Taiwan J Obstet Gynecol 2012;51:426e9.
[14] Chang YW, Chang CM, Sung PL, Yang MJ, Li WH, Li HY, et al. An overview of a
30-year experience with amniocentesis in a single tertiary medical center in
Taiwan. Taiwan J Obstet Gynecol 2012;51:206e11.
[15] Chang YW, Chen LC, Chen CY, Yeh CC, Cheng LY, Lai YL, et al. Robertsonian
translocations: an overview of a 30-year experience in a single tertiary
medical center in Taiwan. J Chin Med Assoc 2013;76:335e9.
[16] Yang JH, Chen MJ, Chen CD, Chen SU, Ho HN, Yang YS. Optimal waiting period
for subsequent fertility treatment after various hysteroscopic surgeries. Fertil
Steril 2013;99. 2092e2096.e3.
K.-H. Tsui et al. / Taiwanese Journal of Obstetrics & Gynecology 53 (2014) 372e375 375[17] Soares SR, Barbosa dos Reis MM, Camargos AF. Diagnostic accuracy of
sonohysterography, transvaginal sonography, and hysterosalpingography in
patients with uterine cavity diseases. Fertil Steril 2000;73:406e11.
[18] Munro MG, Abbott JA, Bradley LD, Howard FM, Jacobs VR, Sokol AI, et al. AAGL
practice report: practice guidelines for management of intrauterine synechiae.
J Minim Invasive Gynecol 2010;17:1e7.
[19] March CM. Management of Asherman's syndrome. Reprod Biomed Online
2011;23:63e76.[20] Lin X, Wei M, Li TC, Huang Q, Huang D, Zhou F, et al. A comparison of intra-
uterine balloon, intrauterine contraceptive device and hyaluronic acid gel in
the prevention of adhesion reformation following hysteroscopic surgery for
Asherman syndrome: a cohort study. Eur J Obstet Gynecol Reprod Biol
2013;170:512e6.
[21] Myers EM, Hurst BS. Comprehensive management of severe Asherman syn-
drome and amenorrhea. Fertil Steril 2012;97:160e4.
